We first assessed the immunofluorescence intensity of selected inflammasome components (NLRP1, NLRP3, NLRP6, AIM2, ASC, Caspase-1, IL-1β and IL-18) in tumor cells compared to normal epithelial cells, for each patient. This evidence concerns the gene NLRP6 and neoplasm.